刺激响应性核酸输送系统在基因治疗中的进步和挑战
Meng Lin1,2, Xianrong Qi1
1Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China.
Pharmaceutics
|May 27, 2023
概括
响应刺激的纳米载体为治疗疾病提供智能基因传递. 这些系统克服了核酸输送的障碍,在临床翻译方面面临挑战,需要进一步研究有效的基因治疗.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 基因治疗 基因治疗
背景情况:
- 基因疗法通过纠正基因,为癌症和神经系统疾病等疾病提供持续治疗.
- 对于基因疗法至关重要的核酸,由于不稳定性和薄弱的膜透性,面临着交付挑战.
- 响应刺激的传递系统正在出现,以克服这些障碍,使控制和向的核酸释放成为可能.
研究的目的:
- 审查用于基因传递的刺激响应纳米载体的原理.
- 为突出突出响应刺激的基因传递系统的进步.
- 讨论这些纳米载体的临床转化所面临的挑战和解决方案.
主要方法:
- 关于用于基因传递的刺激响应纳米载体的当前文献的综述.
- 在纳米载体设计中使用的各种刺激 (pH,氧化还原,酶,光,磁场,超声波) 的分析.
- 检查与基于纳米载体的基因疗法相关的临床前和临床挑战.
主要成果:
- 响应刺激的纳米载体可以智能地控制核酸的释放,并针对特定的网站.
- 已经开发了各种纳米载体系统,利用内源和外部刺激.
- 大多数系统仍然处于临床前阶段,需要解决诸如转染效率,安全性,制造和非目标效应等问题.
结论:
- 对刺激有反应的纳米载体对推进基因疗法有很大的前景.
- 解决当前的挑战对于成功的临床翻译至关重要.
- 进一步的研究将加速这些先进的交付系统的开发和应用.
相关概念视频
Gene Therapy
25.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.6K
Microorganisms in Medicine and Therapeutics
74
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
74


